Key result
Patients with suspected AMI and ST-T changes without enzyme rise had a 1-year mortality of 13%, significantly lower than the 31% mortality observed in patients with non-Q-wave AMIs.
Why the study?
Does the presence of ST-T changes without serum enzyme rise confer a different 1-year mortality risk compared to non-Q-wave AMI in patients with suspected AMI?
Cohort (n=927)
Does the presence of ST-T changes without serum enzyme rise confer a different 1-year mortality risk compared to non-Q-wave AMI in patients with suspected AMI?
Patients with suspected AMI who develop ST-T changes without enzyme elevation have a substantial 1-year mortality (13%), though lower than those with non-Q-wave AMI (31%), with ST depression conferring higher risk than T-wave inversion.
Answers are grounded in this paper and cite their sources.
Substantial mortality risk persists despite absent enzyme rise; leaves open whether isolated ST-T changes warrant distinct stratification from non-Q-wave AMI.
We evaluated the prognosis for 419 patients admitted to hospital due to suspected acute myocardial infarction (AMI) who developed ST-T changes, but no rise in serum enzyme activity, and compared it to that of 508 patients developing non-Q-wave AMIs. We conclude that these patients have a high 1-year mortality (13%), although significantly lower than in patients with non-Q-wave AMIs (31%). The mortality is higher in patients with only ST depression (n = 86; 22%) than in patients with only T-wave inversion (n = 264; 8%).
No takes yet. Share an insight, caveat, or question.
Karlson et al. (2008) conducted a cohort in Suspected acute myocardial infarction (AMI) (n=927). ST-T changes with no rise in serum enzyme activity vs. Non-Q-wave AMIs was evaluated on 1-year mortality. Patients with suspected AMI and ST-T changes without enzyme rise had a 1-year mortality of 13%, significantly lower than the 31% mortality observed in patients with non-Q-wave AMIs.
Synapse has enriched 10 related papers. Consider them for comparative context: